Small molecule targeting CD47-SIRPα pathway: Insilico Medicine achieves its first major milestone in Fosun Pharma collaboration with the nomination of preclinical candidate for QPCTL
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of ...
